This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centaurus Biopharma Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Laicun Li: Innovator in Pharmaceutical Composition
Introduction
Laicun Li is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to solid pharmaceutical compositions. His work emphasizes the importance of stability, dissolution rate, and bioavailability in drug formulation.
Latest Patents
Laicun Li holds a patent for a solid pharmaceutical composition containing a 1,3,5-triazine derivative or a pharmaceutically acceptable salt thereof. This composition includes 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazine-2-amine. The preparation method for this composition ensures that it has good stability, a fast dissolution rate, and high bioavailability, making it suitable for clinical production and use.
Career Highlights
Throughout his career, Laicun Li has worked with prominent pharmaceutical companies, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Laicun Li has collaborated with several professionals in the field, including Yuanyuan Sun and Shan Zhou. These collaborations have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Laicun Li's contributions to pharmaceutical innovation highlight his dedication to improving drug formulations. His patent reflects a significant advancement in the field, showcasing his expertise and commitment to enhancing clinical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile